Twist Bioscience Corporation — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-15.8% -$3M
$-25M
Free Cash Flow↓-46.8% -$11M
$-35M
Investing Cash Flow↓-546.7% -$8M
$-10M
Financing Cash Flow↓-98.3% -$18M
$298K
Capex↑+339.8% +$8M
$10M
Acquisitions
$0
Stock-Based Comp↑+10.7% +$1M
$13M
Debt Repaid
$0
D&A↓-2.9% -$186K
$6M
SBC Allocated Expense↑+10.7% +$1M
$13M
SBC Unrecognized Cost
—